【New Stock Listing】Four new stocks will be suspended today, with LAIFUAL's margin subscription oversubscribed by 2,764 t…

Today, four new stocks were oversubscribed, with LAIFUAL being the hottest at 2,764 times. XUNLONG SCITECH, TH MEDICAL-B, and JIANGXI BIO were also oversubscribed at 1,179 times, 681 times, and 218 times, respectively. The aforementioned new stocks are expected to start trading in the dark market on the 29th of this month and will be listed on the main board of the Stock Exchange on the 30th

According to a report from Economic News Agency on the 25th, four new stocks have been oversubscribed today. Market news reveals that the core component provider for precision robotic transmission, LAIFUAL (03952), has a margin subscription oversubscription ratio of 2764.68 times, with a margin subscription amount of HKD 158.916 billion, making it the hottest stock among the four new listings. The stock plans to globally offer 13.4419 million shares, with approximately 5% allocated for public offering in Hong Kong and the remainder for international offering. The price per share ranges from HKD 77 to HKD 85.5, with a minimum investment of 100 shares, resulting in an entry fee of HKD 8,636.22, raising a maximum of HKD 1.149 billion. CMB International is the exclusive sponsor.

XUNLONG SCITECH (06715) has a margin subscription oversubscription ratio of 1179.7 times, with a margin subscription amount of HKD 145.592 billion. The stock plans to globally offer 16.3329 million shares, with 10% for public offering in Hong Kong and the remainder for international offering, priced at HKD 75.5 per share, raising a maximum of HKD 1.233 billion. The minimum investment is 100 shares, resulting in an entry fee of HKD 7,626.14. The joint sponsors are CITIC Securities and CITIC Construction Investment International.

The surgical robot company TH MEDICAL (02697) has a margin subscription oversubscription ratio of 681.43 times, with a margin subscription amount of HKD 32.941 billion. The stock plans to globally offer 3.5647 million shares, with 10% for public offering in Hong Kong and the remainder for international offering, priced between HKD 119.3 and HKD 135.4 per share, raising a maximum of HKD 483 million. The minimum investment is 20 shares, resulting in an entry fee of HKD 2,735.3. The joint sponsors are CICC and DBS Group. The company has not introduced cornerstone investors this time.

JIANGXI BIO (06915) has a margin subscription oversubscription ratio of 218.6 times, with a margin subscription amount of HKD 10.391 billion. JIANGXI BIO plans to globally offer 36.2345 million H shares, with a sale price ranging from HKD 9.33 to HKD 13.06 per share, raising a maximum of HKD 470 million. CICC and China Merchants Securities International are its joint sponsors.

The above six new stocks are expected to conduct dark trading on the 29th of this month and are anticipated to be listed on the main board of the Stock Exchange on the 30th. (ul)